OXFORD IMMUNOTEC LTD has a total of 31 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in United Kingdom, United States and China. Its main competitors in its focus markets measurement, biotechnology and pharmaceuticals are EUROGENETICS NV, TECHLAB INC and EXPRESSION PATHOLOGY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 9 | |
#2 | United States | 6 | |
#3 | China | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | Australia | 3 | |
#7 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Pharmaceuticals | |
#4 | Basic materials chemistry | |
#5 | Organic fine chemistry | |
#6 | Chemical engineering | |
#7 | Environmental technology | |
#8 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Durrant Ian | 9 |
#2 | Day Toni | 8 |
#3 | Tasker Scott | 8 |
#4 | Bampton Maxine | 5 |
#5 | O'Keeffe Aisling | 5 |
#6 | Amicosante Massimo | 4 |
#7 | Lalvani Ajit | 4 |
#8 | Dwyer Timothy Stuart | 2 |
#9 | Turner Simon William | 2 |
#10 | Maxine Bampton | 1 |
Publication | Filing date | Title |
---|---|---|
GB202101078D0 | Fragment pools | |
GB201605210D0 | Assay | |
CN107110862A | Mycobacterium tuberculosis protein | |
GB201006950D0 | Detecting cell-mediated immunity to borrelia | |
GB0904312D0 | Illumination system | |
GB0823492D0 | Antigenic peptides and uses thereof | |
GB0819422D0 | Diagnostic assay | |
GB0813439D0 | Diagnosis using a T cell assay | |
GB0619853D0 | Preparation method | |
GB0415860D0 | Solid supports | |
AU2002219338B2 | Assay to determine efficacy of treatment for mycobacterial infection |